Summit Therapeutics Inc. SMMT

Updated: 7 Sep 2026

NASDAQ | Biotech | Biotechnology / Oncology

No signal published yet

We already track Summit Therapeutics and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Summit Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Biotechnology / Oncology
We're already tracking Summit Therapeutics Inc. — here are the latest events we've registered

Recent News

  • In August 2026, Summit Therapeutics published primary Phase III HARMONi trial results in The Lancet Oncology, demonstrating statistically significant progression-free survival for ivonescimab in non-small cell lung cancer. In September 2026, partner Akeso reported positive overall survival data from the Phase III HARMONi-2 trial comparing ivonescimab monotherapy against pembrolizumab. The U.S. FDA is currently reviewing Summit's Biologics License Application for ivonescimab with a target PDUFA action date of November 14, 2026.

What Firelda Watch includes for Summit Therapeutics Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Summit Therapeutics Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Hansa Biopharma AB (publ)
HNSA
HOLD
Bioarctic
BIOA B
BUY
Sprint Bioscience AB (publ)
SPRINT
NEUTRAL
Xbrane Biopharma AB (publ)
XBRANE
HOLD
SynAct Pharma AB
SYNACT
HOLD

Biotech

More companies in this sector

Want to follow Summit Therapeutics Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Summit Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Summit Therapeutics Inc. SMMT
Summit Therapeutics — follow and we'll monitor it
Follow Summit Therapeutics free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.